OnabotulinumtoxinA
Composition
This formulation contain Onabotulinumtoxin A as active pharmaceutical ingrediant.
Indications
It is indicated for the treatment of various medical conditions including chronic migraine, upper limb spasticity, cervical dystonia, blepharospasm, and primary axillary hyperhidrosis.
Side effects
Common side effects include injection site pain, headache, eyelid ptosis, muscle weakness, and dry mouth.
Precautions
Use with caution in patients with neuromuscular disorders, infection at the injection site, or who are receiving aminoglycoside antibiotics.
Contraindications
Contraindicated in patients with known hypersensitivity to any botulinum toxin product
Dosage and administration
As Directed by healthcare provider.
Countries
US, Europe
Available Forms
Powder for injection.
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai